Filing Details
- Accession Number:
- 0001437749-21-018558
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-08-04 18:12:03
- Reporting Period:
- 2021-08-02
- Accepted Time:
- 2021-08-04 18:12:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
787253 | Natural Alternatives International Inc | NAII | Medicinal Chemicals & Botanical Products (2833) | 841007839 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1115556 | A Mark Ledoux | 1535 Faraday Avenue Carlsbad CA 92008 | Ceo/Chairman | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2021-08-02 | 5,300 | $17.36 | 168,412 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-03 | 4,700 | $17.44 | 163,712 | No | 4 | S | Direct | |
Common Stock | Disposition | 2021-08-02 | 5,200 | $17.37 | 491,705 | No | 4 | S | Indirect | By LeDoux Family Limited Partnership |
Common Stock | Disposition | 2021-08-03 | 4,800 | $17.44 | 486,905 | No | 4 | S | Indirect | By LeDoux Family Limited Partnership |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Indirect | By LeDoux Family Limited Partnership |
No | 4 | S | Indirect | By LeDoux Family Limited Partnership |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 69,416 | Indirect | By IRA |
Common Stock | 7,200 | Indirect | By Self as Custodian for Marcelle Jeannette LeDoux |
Common Stock | 800 | Indirect | By Self as Custodian for Jean-Marc Emile LeDoux |
Common Stock | 6,000 | Indirect | By Self as Custodian for Aimee LeDoux |
Footnotes
- This transaction represents a sale pursuant to a Programmed Plan of Transactions Under Rule 10b5-1(c) of the Securities Exchange Act included as an Exhibit to Form 8-K filed with the SEC on March 26, 2021.
- Average sale price for sales between $17.00 and $17.50.
- Average sale price for sales between $17.40 and $17.64.